US Patent

US12303635 — Dispensing device and pharmaceutical composition for the treatment of rhinitis

Composition of Matter · Assigned to Glenmark Specialty SA · Expires 2039-04-08 · 13y remaining

Vulnerability score 0/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a nasal dispensing device and a pharmaceutical composition containing mometasone, an ester or salt thereof, and olopatadine or its salt.

USPTO Abstract

A nasal dispensing device and pharmaceutical composition includes a container; a dispenser head having at least a pump, a dispensing channel, and a dispensing orifice; a dip tube; and a pharmaceutical composition comprising mometasone, an ester thereof (e.g., mometasone furoate), or a salt thereof and olopatadine or its salt (e.g., olopatadine hydrochloride). The container can have a conically shaped internal bottom, angled downwardly toward a center, and a further angularly deepened well, centrally located, with the dip tube extending into the well. An optional cap is provided that includes a sealing sleeve communicating in a seal tight manner with a perimeter of a lateral wall of the dispenser head.

Drugs covered by this patent

Patent Metadata

Patent number
US12303635
Jurisdiction
US
Classification
Composition of Matter
Expires
2039-04-08
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Glenmark Specialty SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.